Goldman says Cepheid (CPHD -8.3%) is oversold, and the pullback may be a buying opportunity. The...
Goldman says Cepheid (CPHD -8.3%) is oversold, and the pullback may be a buying opportunity. The firm says that despite the gloomy FY13 margin forecast, the company has a "healthy" long-term growth story. Its a leader in the rapid MDx market, and has a solid new prduct pipeline.
From other sites
at Zacks.com (Mar 27, 2015)
at 4-traders.com (Mar 24, 2015)
at Investor's Business Daily (Jan 14, 2015)
at Nasdaq.com (Jan 6, 2015)
at Benzinga.com (Dec 18, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs